REPORT DESCRIPTION
Budesonide Inhaler Market – Overview
Budesonide is a medication that is used to prevent symptoms of asthma. It is a corticosteroid or steroid
(cortisone-like medicine). The medication prevents inflammation in the lungs to decrease the severity of
asthma attack. Inhaled budesonide may be used with other asthma medicines such as bronchodilators,
which are also used to open up narrowed breathing passages in the lungs. Budesonide is available in
several forms such as powders, suspensions, and tablets. In powder form, the medication can be inhaled by
mouth using an inhaler. It can also be used as suspension to inhale by mouth using a special jet nebulizer
(machine that turns medication into a mist that can be inhaled). Some of the trade names under which
budesonide is sold are Pulmicort, Rhinocort, and Entocort.
The global budesonide inhaler market size was valued at US$ 5.25 billion in 2017, and is expected to
witness a CAGR of 5.8% over the forecast period (2018 – 2026).